# A Study To Evaluate The Contact Sensitization Potential Of Tazarotene Foam On Skin In Healthy Volunteers

> **NCT01114841** · PHASE1 · COMPLETED · sponsor: **Stiefel, a GSK Company** · enrollment: 254 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** Tazarotene Foam
- **DRUG:** Vehicle Foam

## Key facts

- **NCT ID:** NCT01114841
- **Lead sponsor:** Stiefel, a GSK Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03-31
- **Primary completion:** 2010-06-26
- **Final completion:** 2010-06-26
- **Target enrollment:** 254 (ACTUAL)
- **Last updated:** 2017-06-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01114841

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01114841, "A Study To Evaluate The Contact Sensitization Potential Of Tazarotene Foam On Skin In Healthy Volunteers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01114841. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*